FDA — authorised 13 August 1993
- Application: NDA020091
- Marketing authorisation holder: ALLIANCE PHARM
- Local brand name: IMAGENT
- Indication: LIQUID — ORAL
- Status: approved
FDA authorised PERFLUBRON on 13 August 1993
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 13 August 1993; FDA has authorised it.
ALLIANCE PHARM holds the US marketing authorisation.